← all drugs
Valproate Sodium Injection
in shortage · Neurology · Snapshot: 2026-10-09
Day 2,109
of this shortage, counting from the FDA's first posting on 12/30/2020
- Manufacturers listed
- Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc.
- Machine-readable
- JSON for this drug
Presentations (2)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Fresenius Kabi USA, LLC | Available | 09/15/2026 |
| Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.